Svenska Cellulosa Ab Sca Class A · OMXSTO:SCA_A

Svenska Cellulosa Ab Sca Class A — SCA — Q3 2013 Earnings Presentation

13 slides from Svenska Cellulosa Ab Sca Class A's earnings presentation, Oct 18, 2013

  1. Slide 1: SCA Interim Report January – September 2013

    SCA Interim Report 1 January – 30 September 2013

  2. Slide 2: Market Update

    Market Update  Tissue  Some growth in Europe and North America  Good growth in emerging markets  Personal Care  Good demand for incontinence products in Europe  Stable demand for feminine care in Western Europe  Good growth in emerging markets  Forest Products  Decreased demand for publicat

  3. Slide 3: Efficiency programs

    Efficiency programs  Hygiene business cost and productivity program  Achieved cost savings Q3 2013: SEK 270m  Annualized cost savings in Q3 2013: approx. EUR 130m  Total annual cost savings of EUR 300m, full effect in 2015  Georgia-Pacific synergies  Achieved cost savings Q3 2013: SEK 120m  A

  4. Slide 4: Summary Q3 2013

    Summary Q3 2013 vs. Q3 2012  Sales growth 6%*  Hygiene business, 7%* • Higher prices • Higher volumes • Good growth in Emerging markets  Forest Products, 6%** • Higher volumes • Higher prices  EBIT increased 12%***  Higher volumes  Higher prices  Cost savings  Operating cash flow decreased 2

  5. Slide 5: Q3 2013 results

    Q3 2013 results SEK millions Q3 Q3 unless otherwise stated 2013 2012 Change, % Change, % Net sales 22,046 22,200 -1 6** EBIT* 2,524 2,285 10 12*** EBIT margin* (%) 11.4 10.3 Profit before tax* 2,256 1,961 15 18*** Earnings per share (SEK) 2.06 0.51 Operating cash flow 2,402 3,029 -21 Debt/Equity rat

  6. Slide 6: Q3 2013 vs. Q2 2013 Summary

    Q3 2013 vs. Q2 2013 Summary  Group  Sales flat  EBIT increased 17%*  Business areas  Personal Care, EBIT flat* - Higher prices - Lower raw material costs - Lower volumes  Tissue, EBIT increased 16%* - Higher prices - Cost savings  Forest Products, EBIT increased 68%* - Lower raw material cost

  7. Slide 7: Summary 9M 2013 vs. 9M 2012

    Summary 9M 2013 vs. 9M 2012  Sales growth 14%*  Hygiene business, 16%* • Acquisitions • Higher volumes • Good growth in Emerging markets  Forest Products, -2%** • Higher volumes • Lower prices  EBIT increased 15%***  Acquisition  Cost savings  Higher volumes  Lower raw material costs  Opera

  8. Slide 8: Personal Care

    Personal Care Q3 2013 vs. Q3 2012  Sales growth 3% (5%*) 3%  Incontinence products increased 5%*  Baby diapers decreased 3%*  Feminine care increased 10%*  Emerging markets increased 6%* Sales (SEKm) Q3 2012 Q3 2013  EBIT decreased 5%** (3%***)  Higher volumes -5%**  Cost savings  Increased

  9. Slide 9: Tissue

    Tissue Q3 2013 vs. Q3 2012 Sales growth 3% (8%*)  Consumer tissue increased 6%* 3%  AFH tissue increased 12%**  Emerging markets increased 13%**  EBIT increased by 17%*** (22%****) Sales (SEKm) Q3 2012 Q3 2013  Higher volumes  Higher prices 17%***  Cost savings  Higher energy and raw materi

  10. Slide 10: Forest Products

    Forest Products Q3 2013 vs. Q3 2012  Sales decreased 15% (+6%*)  Publication papers, decreased sales • Lower prices • Divestments -15%  Kraftliner, increased sales • Higher prices Sales (SEKm) Q3 2012 Q3 2013 • Solid-wood products, increased sales • Higher prices and volumes  Pulp, increased sal

  11. Slide 11: Summary

    Summary  Higher sales and profit in Tissue and Forest Products  Higher sales and slightly lower profit in Personal Care  Efficiency programs delivering according to plan  Strengthening emerging markets presence  Offer for Vinda  Investment in India  Several product launches  Inauguration of

  12. Slide 12: Q&A

    Q&A October 18, 2013 SCA Interim Report Q3 2013 12

  13. Slide 13: Slide 13

SCA — Q3 2013 Earnings Presentation on 6ix